bupropion has been researched along with Asthma, Bronchial in 1 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Excerpt | Relevance | Reference |
---|---|---|
"We conducted a 12-week open-label study of bupropion in 18 depressed asthma patients." | 9.12 | Bupropion in the treatment of outpatients with asthma and major depressive disorder. ( Brown, ES; Khan, DA; Rush, AJ; Vornik, LA, 2007) |
"We conducted a 12-week open-label study of bupropion in 18 depressed asthma patients." | 5.12 | Bupropion in the treatment of outpatients with asthma and major depressive disorder. ( Brown, ES; Khan, DA; Rush, AJ; Vornik, LA, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, ES | 1 |
Vornik, LA | 1 |
Khan, DA | 1 |
Rush, AJ | 1 |
1 trial available for bupropion and Asthma, Bronchial
Article | Year |
---|---|
Bupropion in the treatment of outpatients with asthma and major depressive disorder.
Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Asthma; Bupropion; Cit | 2007 |